Inbunden, Engelska, 2018

Resistance to Ibritumomab in Lymphoma

Av Makoto Hosono, Jean-François Chatal

Del 18 i serien Resistance to Targeted Anti-Cancer Therapeutics

1114 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab.

Produktinformation

Utgivningsdatum: 2018-05-07
Mått: 155 x 235 x 16 mm
Vikt: 378 g
Format: Inbunden
Språk: Engelska
Serie: Resistance to Targeted Anti-Cancer Therapeutics
Antal sidor: 158
Upplaga: 18001
Förlag: Springer International Publishing AG
ISBN: 9783319782379

Utforska kategorier

Mer om författaren

Makoto Hosono, MD, PhD, is a Professor of Radiology and Nuclear Medicine, Institute of Advanced Clinical Medicine, Kindai University Faculty of Medicine, Japan, and serves as a member of Committee 3, International Commission on Radiological Protection. Jean-François Chatal, MD, PhD, is an Emeritus Professor of Nuclear Medicine at the University of Nantes, France. He is one of the international leaders who developed radioimmunotherapy, that is, therapy using radiolabeled anti-tumor antibodies. He created and headed an INSERM research laboratory and also initiated the installation of a cyclotron institute termed ARRONAX for the production of novel radionuclides for nuclear medicine.

Betyg & recensioner

0 recensioner

Inga recensioner tillgängliga.